ANALISIS COST OF ILLNESS PADA PASIEN DIABETES MELLITUS DENGAN TERAPI GLIMEPIRIDE-METFORMIN RAWAT JALAN PESERTA BPJS DI PUSKESMAS KETAPANG II KOTA SAMPIT

Authors

  • Nur Ghina Apriliana Muhammadiyah Malang University
  • Liza Pristianty Airlangga University
  • Ika Ratna Hidayati Muhammadiyah Malang University

DOI:

https://doi.org/10.21776/ub.pji.2023.008.02.5

Keywords:

Cost of Illness, Direct Medical Cost, Direct Non-medical Cost, Indirect Cost, Diabetes Mellitus, Community Health Center

Abstract

Background : Diabetes mellitus is a chronic disease that affects the costs incurred by patients during illness. The financing issued for the treatment of diabetes mellitus diseases can be measured using Cost of Illness analysis.

Research Objectives : To find out the total cost of treatment of diabetes mellitus patients BPJS participants with Glymepiride-Metformin therapy for one year.

Method : This study used a non-probability sampling technique with an accidental sampling method. This research conducted at Ketapang II Health Center with sample total 45 people. The instrument used a structured interview which was previously tested for validity. Data were analyzed using Microsoft Excel.

Result and Conclusion : The estimate total cost of treatment of diabetes mellitus with outpatient glimepiride-metformin therapy of Indonesia Health Insurance participants at Ketapang II Health Center in Sampit city for one year is Rp.623.760 - Rp.4.475.520. The direct medical cost per patient is Rp.143.760 - Rp.2.787.120. Non-medical direct cost is Rp.0 - Rp.188.400. Indirect cost is Rp.480.000 - Rp.1.500.000. High cost are more expensive but the frequency of visits and patient compliance are orderly so that the therapeutic effect achieved is good, while the low cost is cheaper but the frequency of patient visits and patient compliance are not orderly so that the therapeutic effect achieved is less good and not maximal.

Author Biographies

  • Nur Ghina Apriliana, Muhammadiyah Malang University
    Nur Ghina Apriliana Mahasiswa Universitas Muhammadiyah Malang Jurusan Farmasi
  • Liza Pristianty, Airlangga University
    Dr. apt. Liza Pristianty, M.Si.,MM. Dosen Universitas Airlangga Surabaya Jurusan Farmasi
  • Ika Ratna Hidayati, Muhammadiyah Malang University
    apt. Ika Ratna Hidayati,S.Farm.,M.Sc. Dosen Universitas Muhammadiyah Malang Program Studi Farmasi

References

American Diabetes Association. (2019). Standards of Medical Care in Diabetes 2019 (Volume 42). Retrieved from https://www.diabetes.org/

Arif, D. (2019). Studi Pola Keterjangkauan Puskesmas Di Kabupaten Lamongan. Swara Bhumi, 1(2), 1–7.

Arnold, J. G. R. (2010). Pharmacoeconomics from theory practice. https://doi.org/978-1-4200-8422-1

Baroroh, F., Solikah, W. Y., & Urfiyya, Q. A. (2016). Analisis biaya terapi Diabetes Melitus tipe 2 Di Rumah Sakit Pku Muhammadiyah Bantul Yogyakarta. Jurnal Farmasi Sains Dan Praktis, I(2), 11–22.

Booth, W., Halawa, A., & Nancye, P. M. (2015). Kepatuhan Diet Pada Penderita Diabetes Melitus Di Club Diabetes Melitus.

Destiani, D., Abdulah, R., & Sinuraya, R. (2014). Cost of Illness dan Cost Containment Analysis Penggunaan Antibiotik Empirik Kombinasi pada Pasien Sepsis di Bandung. Indonesian Journal of Clinical Pharmacy, 1(4), 0–0.

Hestiana, D. wahyu. (2017). Faktor-Faktor Yang Berhubungan Dengan Kepatuhan Dalam Pengelolaan Diet Pada Pasien Rawat Jalan Diabetes Mellitus Tipe 2 Di Kota Semarang. Journal of Health Education, 2(2), 137–145. https://doi.org/10.15294/jhe.v2i2.14448

International Diabetes Federation. (2013). Diabetes Atlas Sixth Edition. In Idf Diabetes Atlas. https://doi.org/2-930229-80-2

Lesmana, T. C., & Sugiman. (2020). Determinan Pemilihan Kelas BPJS Peserta Jaminan Kesehatan Nasional Mandiri. Jurnal Endurnce : Kajian Ilmiah Problema Kesehatan, 5(2), 216–226.

Menteri Kesehatan Republik Indonesia. (2018). Hasil Utama Riset Kesehatan Dasar Jawa Timur 2018. Jakarta: Badan Penelitian Dan Pengembangan Kesehatan, Kementrian Kesehatan Republik Indonesia, 1–82.

Mildawati, Diani, N., & Wahid, A. (2019). Hubungan Usia, Jenis Kelamin dan Lama Menderita Diabetes dengan Kejadian Neuropati Perifer Diabateik. Caring Nursing Journal, 3(2), 31–37.

Sari, L. S. (2017). Analisis Biaya Akibat Sakit serta Kualitas Hidup Pasien Diabetes Mellitus Tipe 2 dengan Penyakit Jantung. Jurnal Ekonomi Kesehatan Indonesia, 1(3). https://doi.org/10.7454/eki.v1i3.1777

Sugiyono, D. P. (2013). Metode Penelitian Kuantitatif, Kualitatif dan R & D. Bandung.

Susanti, E. F. N. (2019). Gambaran faktor risiko terjadinya diabetes melitus pada penderita diabetes melitus tipe 2. Jurnal Keperawatan, 1–14. Retrieved from http://eprints.ums.ac.id/id/eprint/71368

Susilo, wulan. (2014). Pengeluaran Kesehatan Karena Penyakit Tuberculosis di Kota Bengkulu. 2014(June), 1–2.

Thabrany, H., Afdhal, P. A. F., & Thobari, J. A. (2013). pedoman penerapan kajian farmakoekonomi (M. Drs. Prih Sarnianto, M.Sc, Apt dr. Zorni Fadia Erie Gusnellyanti, S.Si, Apt, Ed.). jakarta.

Wijaya, I. (2015). Manfaat kombinasi glimepirid dan metformin pada tatalaksana DM tipe 2. Farmasi Dan Ilmu Kesehatan, 3–7.

Yanada, F. (2015). Faktor Resiko Kejadian Diabetes Mellitus 2 pada Penderita Diabetes Mellitus di RSUD dr.Haulusyy Ambon Tahun 2014 (pp. 36–54). pp. 36–54.

Yuniarti, E. (2015). Analisis Biaya Terapi Penyakit Diabetes Melitus Pasien Jaminan Kesehatan Nasional di RS PKU Muhammadiyah Yogyakarta. Jurnal Kebijakan Kesehatan Indonesia, 04(03), 97–103.

Downloads

Published

2023-06-29

Issue

Section

Articles